Crinetics Pharmaceuticals Total Long-Term Assets 2017-2024 | CRNX
Crinetics Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $0.060B, a 9.11% decline year-over-year.
- Crinetics Pharmaceuticals total long-term assets for 2023 were $0.061B, a 775.29% increase from 2022.
- Crinetics Pharmaceuticals total long-term assets for 2022 were $0.007B, a 11.07% increase from 2021.
- Crinetics Pharmaceuticals total long-term assets for 2021 were $0.006B, a 5.75% increase from 2020.